Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 3—June 2001
Research

Melioidosis: An Emerging Infection in Taiwan?

Po-Ren Hsueh*, Lee-Jene Teng*, Li-Na Lee*†, Cheong-Ren Yu*, Pan-Chyr Yang*, Shen-Wu Ho*†, and Kwen-Tay Luh*Comments to Author 
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan; †National Taiwan University College of Medicine, Taipei, Taiwan

Main Article

Table 1

Clinical characteristics of 15 patients in Taiwan with invasive infections caused by Burkholderia pseudomallei

Patient
no./ref Age/
sex Travel
history Underlying diseases/associated
conditions Clinical
diagnosis Isolate
source (date) Treatment Out-come
1 (13) 46/M Philippines Near drowning Cavitary pneumonia Blood (9/82) Cephalothin, amikacin (30 d) Surv
2 (14) 75/F None Liver cirrhosis, uremia, DM Pneumonia, peritoni-tis Blood, ascites (8/94) Cefazolin, gentamicin (1 d) Died
3 (14) 70/M None None Pneumonia Blood (8/94) Ceftazidime (30 d), amoxicillin-clavulanate (3 mo) Surv
4 (15) 70/M China None Mycotic aneurysm Blood (11/94); aortic tissue (12/94) Ceftazidime (35 d); amoxicillin-clavulanate (6 mo) Surv
5 (16) 75/M None DM Pneumonia Blood (11/96) Ceftazidime (14 d); amoxicillin-clavulanate (2 mo ) Surv
6 (17) 51/M Burma DM Pneumonia, adrenal gland abscess Blood (7/97) Ceftazidime (2 d);cotrimoxazole (60 d) Surv
7 (18) 40/M None DM Pneumonia, ARDS Blood (7/97) Moxalactam 9 d); netilmicin (9 d); erythromycin (9 d) Died
8 (PR) 56/M Thailand None Pneumonia Blood-A (11/96) Ceftazidime, gentamicin (1 d) Died
9 (PR) 67/M None COPD Pneumonia Blood-B (1/97) Ceftazidime (14 d); amoxicillin-clavulanate (2 mo) Surv
10 (PR) 73/M None Prostate cancer with bone metastasis; DM; cyproterone and leuprolide acetate use Cavitary pneumonia Lung aspirate -C1 (7/97); sputum-C2 (7/97) Ciprofloxacin (5 mo) Surv
11 (PR) 76/F None None Septic arthritis, subcutaneous abscess Blood-D1; blood-D2; synovial fluid-D3; abscess fluid-D4; wound drainage -D5; all 9/98 Ciprofloxacin (4 mo); surgical drainage Surv
12 (PR) 58/M None None Subcutaneous abscess Abscess fluid-E1 (4/99); abscess fluid-E2 (2/2000) Piperacillin (10 d); ciprofloxacin (14 d) Surv
13 (PR) 66/M None DM Pneumonia, septic arthritis, subcutaneous abscess Lung aspirate -F1 (5/99); synovial fluid-F2 (5/99); abscess aspirate -F3 (1/2000) Imipenem (10 d); ciprofloxacin (2 mo); meropenem (1 mo); amoxicillin-clavulanate (4 mo) Surv
14 (PR) 74/M None COPD Pneumonia Blood-G (9/99) Ceftazidime, amikacin (14 mo); ciprofloxacin (2 mo) Surv
15 (PR) 70/M None COPD, TB Pneumonia, empyema, ARDS Blood-H1 Blood-H2 (1/2000) Ceftazidime, amikacin (1 mo) Died

Abbreviations used in this table: ARDS, adult respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; d, day; DM, diabetes mellitus; mo, month; PR, present report; surv, survived.

Main Article

Page created: April 26, 2012
Page updated: April 26, 2012
Page reviewed: April 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external